Safety Alert for Calibrator Immunodiagnosis Vitros for 25-OH Vitamin D Total, Record no. 80145901419, lots: See Annex Distribution List.

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by Johnson & Johnson do Brasil Ind. e Com. de Prod. para Saúde Ltda.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    1351
  • Date
    2014-01-30
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    Research indicates that previous batches of the VITROS® 25-OH total vitamin D calibrator may have been equally affected by this problem, and therefore recommend that previously reported results be generated using VITROS® 25-OH vitamin D total calibrators , Lots 0091 to 0235. The laboratory may wish to review the quality control results used to verify deviations in calibration. Results lower than the target mean may indicate potentially biased test results. Discuss any concerns with the Laboratory Medical Director or the doctor who requested the examination. The results from this or any other diagnostic test should be used and interpreted only in the context of the whole clinical picture. The company informs that this event fits into the situation whose use of, or exposure to, the affected product may cause adverse health effects that are clinically reversible or temporary, or in which the likelihood of serious adverse health consequences is remote, as defined in legislation relevant.
  • Reason
    The company that owns the registry informs that a manufacturer's investigation, ortho clinical diagnostics, inc. (ocd), has identified that certain immunological products vitros® 25-oh vitamin d total calibrators, lot 0091 to 0235, used with the vitros reagent packs ® immunodiagnostic products 25-oh vitamin d total, may cause negative deviation in results. as a result, you should immediately discontinue use of all batches vitros® 25-oh vitamin d total calibrator and reagent (lots 0200, 0210, 0220, 0230 and 0235).
  • Action
    The company directs that: i- Immediately discontinue the use of VITROS® 25-OH Calibrator and Reagent Vitamin D Total (Lots 0200, 0210, 0220, 0230 and 0235); ii - Review the reported results from Lots 0091 to 0235 VITROS® 25-OH Vitamin D Total. Your lab can review QC results to verify calibration. Results below the target mean may potentially indicate deviation in the results; iii - Discuss any concerns with the Medical Director of the Laboratory or with the doctor who requested the examination; iv - Complete the receipt of this notification by February 15, 2014. See Letter to the Client, attached to this alert.

Manufacturer